Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2

Randomized trials in acute promyelocytic leukemia patients have shown that treatment with a combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) is superior in efficacy to monotherapy, with significantly decreased mortality. So far, there are little data available to explain the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jambrovics, Károly, Uray, Iván P., Keillor, Jeffrey W., Fésüs, László, Balajthy, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139906/
https://www.ncbi.nlm.nih.gov/pubmed/32168763
http://dx.doi.org/10.3390/cancers12030648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139906/
https://www.ncbi.nlm.nih.gov/pubmed/32168763
http://dx.doi.org/10.3390/cancers12030648

Ejemplares similares